Frequent DPH3 promoter mutations in skin cancers

Oncotarget

Volumn 6, Issue 34, 2015, Pages 35922-35930

  Denisova, Evgeniya ^a   Heidenreich, Barbara ^a   Nagore, Eduardo ^b   Sivaramakrishna Rachakonda, P ^a   Hosen, Ismail ^a   Akrap, Ivana ^c   Traves, Víctor ^b   García Casado, Zaida ^b   López Guerrero, José Antonio ^b   Requena, Celia ^b   Sanmartin, Onofre ^b   Serra Guillén, Carlos ^b   Llombart, Beatriz ^b   Guillén, Carlos ^b   Ferrando, Jose ^d   Gimeno, Enrique ^d   Nordheim, Alfred ^a,c   Hemminki, Kari ^a,e   Kumar, Rajiv ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b INSTITUTO VALENCIANO DE ONCOLOGÍA   (Spain)

^c UNIVERSITY OF TÜBINGEN   (Germany)

^d HOSPITAL ARNAU DE VILANOVA   (Spain)

^e LUND UNIVERSITY   (Sweden)

Author keywords

DPH3; Noncoding mutations; OXNAD1; Skin cancers; Whole exome sequencing

Indexed keywords

T CELL FACTOR PROTEIN; TRANSCRIPTION FACTOR ETS; CARRIER PROTEIN; DPH3 PROTEIN, HUMAN;

ARTICLE; BASAL CELL CARCINOMA; BINDING SITE; CONTROLLED STUDY; DPH3 GENE; EXOME; GENE; GENETIC TRANSCRIPTION; GENETIC VARIABILITY; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MELANOMA; MELANOMA CELL LINE; OXNAD1 GENE; PIGMENTED NEVUS; PROMOTER REGION; REAL TIME POLYMERASE CHAIN REACTION; SKIN CANCER; SKIN CARCINOMA; SOMATIC MUTATION; TRANSCRIPTION INITIATION SITE; ULTRAVIOLET RADIATION; AMINO ACID SEQUENCE; GENETICS; MOLECULAR GENETICS; MUTATION; NUCLEOTIDE SEQUENCE; PATHOLOGY; SKIN TUMOR; SQUAMOUS CELL CARCINOMA;

AMINO ACID SEQUENCE; BASE SEQUENCE; CARCINOMA, SQUAMOUS CELL; CARRIER PROTEINS; HUMANS; MELANOMA; MOLECULAR SEQUENCE DATA; MUTATION; PROMOTER REGIONS, GENETIC; SKIN NEOPLASMS;

EID: 84946893392     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.5771     Document Type: Article

References (47)

1. Horn S, Figl A, Rachakonda PS, Fischer C, Sucker A, Gast A, Kadel S, Moll I, Nagore E, Hemminki K, Schadendorf D and Kumar R. TERT promoter mutations in familial and sporadic melanoma. Science. 2013; 339:959-961.
2. Huang FW, Hodis E, Xu MJ, Kryukov GV, Chin L and Garraway LA. Highly recurrent TERT promoter mutations in human melanoma. Science. 2013; 339:957-959.
3. Weinhold N, Jacobsen A, Schultz N, Sander C and Lee W. Genome-wide analysis of noncoding regulatory mutations in cancer. Nat Genet. 2014; 46:1160-1165.
4. Fredriksson NJ, Ny L, Nilsson JA and Larsson E. Systematic analysis of noncoding somatic mutations and gene expression alterations across 14 tumor types. Nat Genet. 2014; 46:1258-1263.
5. Killela PJ, Reitman ZJ, Jiao Y, Bettegowda C, Agrawal N, Diaz LA, Jr., Friedman AH, Friedman H, Gallia GL, Giovanella BC, Grollman AP, He TC, He Y, Hruban RH, Jallo GI, Mandahl N, et al. TERT promoter mutations occur frequently in gliomas and a subset of tumors derived from cells with low rates of self-renewal. Proc Natl Acad Sci U S A. 2013;110:6021-6.
6. Heidenreich B, Rachakonda PS, Hemminki K and Kumar R. TERT promoter mutations in cancer development. Current Opinions in Genetics & Development. 2014; 24:30-37.
7. Mansour MR, Abraham BJ, Anders L, Berezovskaya A, Gutierrez A, Durbin AD, Etchin J, Lawton L, Sallan SE, Silverman LB, Loh ML, Hunger SP, Sanda T, Young RA and Look AT. Oncogene regulation. An oncogenic superenhancer formed through somatic mutation of a noncoding intergenic element. Science. 2014; 346:1373-1377.
8. Scholz SL, Horn S, Murali R, Moller I, Sucker A, Sondermann W, Stiller M, Schilling B, Livingstone E, Zimmer L, Reis H, Metz CH, Zeschnigk M, Paschen A, Steuhl KP, Schadendorf D, et al. Analysis of SDHD promoter mutations in various types of melanoma. Oncotarget. 2015 Jul 27. [Epub ahead of print] PMID: 26327518.
9. Alexandrov LB, Nik-Zainal S, Wedge DC, Aparicio SA, Behjati S, Biankin AV, Bignell GR, Bolli N, Borg A, Borresen-Dale AL, Boyault S, Burkhardt B, Butler AP, Caldas C, Davies HR, Desmedt C, et al. Signatures of mutational processes in human cancer. Nature. 2013; 500:415-421.
10. Hodis E, Watson IR, Kryukov GV, Arold ST, Imielinski M, Theurillat JP, Nickerson E, Auclair D, Li L, Place C, Dicara D, Ramos AH, Lawrence MS, Cibulskis K, Sivachenko A, Voet D, et al. A landscape of driver mutations in melanoma. Cell. 2012; 150:251-263.
11. Krauthammer M, Kong Y, Ha BH, Evans P, Bacchiocchi A, McCusker JP, Cheng E, Davis MJ, Goh G, Choi M, Ariyan S, Narayan D, Dutton-Regester K, Capatana A, Holman EC, Bosenberg M, et al. Exome sequencing identifies recurrent somatic RAC1 mutations in melanoma. Nat Genet. 2012; 44:1006-1014.
12. Berger MF, Hodis E, Heffernan TP, Deribe YL, Lawrence MS, Protopopov A, Ivanova E, Watson IR, Nickerson E, Ghosh P, Zhang H, Zeid R, Ren X, Cibulskis K, Sivachenko AY, Wagle N, et al. Melanoma genome sequencing reveals frequent PREX2 mutations. Nature. 2012; 485:502-506.
13. Gartner JJ, Parker SC, Prickett TD, Dutton-Regester K, Stitzel ML, Lin JC, Davis S, Simhadri VL, Jha S, Katagiri N, Gotea V, Teer JK, Wei X, Morken MA, Bhanot UK, Program NCS, et al. Whole-genome sequencing identifies a recurrent functional synonymous mutation in melanoma. Proc Natl Acad Sci U S A. 2013; 110:13481-13486.
14. Wei X, Walia V, Lin JC, Teer JK, Prickett TD, Gartner J, Davis S, Stemke-Hale K, Davies MA, Gershenwald JE, Robinson W, Robinson S, Rosenberg SA and Samuels Y. Exome sequencing identifies GRIN2A as frequently mutated in melanoma. Nat Genet. 2011; 43:442-446.
15. Aydin IT, Melamed RD, Adams SJ, Castillo-Martin M, Demir A, Bryk D, Brunner G, Cordon-Cardo C, Osman I, Rabadan R and Celebi JT. FBXW7 mutations in melanoma and a new therapeutic paradigm. J Natl Cancer Inst. 2014; 106:dju107.
16. Stark MS, Woods SL, Gartside MG, Bonazzi VF, DuttonRegester K, Aoude LG, Chow D, Sereduk C, Niemi NM, Tang N, Ellis JJ, Reid J, Zismann V, Tyagi S, Muzny D, Newsham I, et al. Frequent somatic mutations in MAP3K5 and MAP3K9 in metastatic melanoma identified by exome sequencing. Nature genetics. 2012; 44:165-169.
17. Nikolaev SI, Rimoldi D, Iseli C, Valsesia A, Robyr D, Gehrig C, Harshman K, Guipponi M, Bukach O, Zoete V, Michielin O, Muehlethaler K, Speiser D, Beckmann JS, Xenarios I, Halazonetis TD, et al. Exome sequencing identifies recurrent somatic MAP2K1 and MAP2K2 mutations in melanoma. Nat Genet. 2012; 44:133-139.
18. The Cancer Genome Atlas Genomic Classification of Cutaneous Melanoma. Cell. 2015; 161:1681-1696.
19. Hollenhorst PC, McIntosh LP and Graves BJ. Genomic and biochemical insights into the specificity of ETS transcription factors. Annu Rev Biochem. 2011; 80:437-471.
20. ENCODE project consortium An integrated encyclopedia of DNA elements in the human genome. Nature. 2012; 489:57-74.
21. Kent WJ, Sugnet CW, Furey TS, Roskin KM, Pringle TH, Zahler AM and Haussler D. The human genome browser at UCSC. Genome Res. 2002; 12:996-1006.
22. Premi S, Wallisch S, Mano CM, Weiner AB, Bacchiocchi A, Wakamatsu K, Bechara EJ, Halaban R, Douki T and Brash DE. Photochemistry. Chemiexcitation of melanin derivatives induces DNA photoproducts long after UV exposure. Science. 2015; 347:842-847.
23. Jayaraman SS, Rayhan DJ, Hazany S and Kolodney MS. Mutational landscape of basal cell carcinomas by wholeexome sequencing. J Invest Dermatol. 2014; 134:213-220.
24. South AP, Purdie KJ, Watt SA, Haldenby S, den Breems NY, Dimon M, Arron ST, Kluk MJ, Aster JC, McHugh A, Xue DJ, Dayal JH, Robinson KS, Rizvi SM, Proby CM, Harwood CA, et al. NOTCH1 mutations occur early during cutaneous squamous cell carcinogenesis. J Invest Dermatol. 2014; 134:2630-2638.
25. Durinck S, Ho C, Wang NJ, Liao W, Jakkula LR, Collisson EA, Pons J, Chan SW, Lam ET, Chu C, Park K, Hong SW, Hur JS, Huh N, Neuhaus IM, Yu SS, et al. Temporal dissection of tumorigenesis in primary cancers. Cancer discovery. 2011; 1:137-143.
26. Vogelstein B, Papadopoulos N, Velculescu VE, Zhou S, Diaz LA, Jr. and Kinzler KW. Cancer genome landscapes. Science. 2013; 339:1546-1558.
27. Wang L, Shi Y, Ju P, Liu R, Yeo SP, Xia Y, Owlanj H and Feng Z. Silencing of diphthamide synthesis 3 (Dph3) reduces metastasis of murine melanoma. PLoS One. 2012; 7:e49988.
28. Liu S, Wiggins JF, Sreenath T, Kulkarni AB, Ward JM and Leppla SH. Dph3, a small protein required for diphthamide biosynthesis, is essential in mouse development. Mol Cell Biol. 2006; 26:3835-3841.
29. Martincorena I, Roshan A, Gerstung M, Ellis P, Van Loo P, McLaren S, Wedge DC, Fullam A, Alexandrov LB, Tubio JM, Stebbings L, Menzies A, Widaa S, Stratton MR, Jones PH and Campbell PJ. Tumor evolution. High burden and pervasive positive selection of somatic mutations in normal human skin. Science. 2015; 348:880-886.
30. Dong M, Su X, Dzikovski B, Dando EE, Zhu X, Du J, Freed JH and Lin H. Dph3 is an electron donor for Dph1-Dph2 in the first step of eukaryotic diphthamide biosynthesis. J Am Chem Soc. 2014; 136:1754-1757.
31. Glatt S, Zabel R, Vonkova I, Kumar A, Netz DJ, Pierik AJ, Rybin V, Lill R, Gavin AC, Balbach J, Breunig KD and Muller CW. heterodimer and its double role in modificationsStructure of the Kti11/Kti13 of tRNA and eukaryotic elongation factor 2. Structure. 2015; 23:149-160.
32. Abdel-Fattah W, Scheidt V, Uthman S, Stark MJ and Schaffrath R. Insights into diphthamide, key diphtheria toxin effector. Toxins. 2013; 5:958-968.
33. Liu S, Bachran C, Gupta P, Miller-Randolph S, Wang H, Crown D, Zhang Y, Wein AN, Singh R, Fattah R and Leppla SH. Diphthamide modification on eukaryotic elongation factor 2 is needed to assure fidelity of mRNA translation and mouse development. Proceedings of the National Academy of Sciences of the United States of America. 2012; 109:13817-13822.
34. Yang SH and Sharrocks AD. SUMO promotes HDACmediated transcriptional repression. Mol Cell. 2004; 13:611-617.
35. Lee SM, Vasishtha M and Prywes R. Activation and repression of cellular immediate early genes by serum response factor cofactors. J Biol Chem. 2010; 285:22036-22049.
36. Buchwalter G, Gross C and Wasylyk B. Ets ternary complex transcription factors. Gene. 2004; 324:1-14.
37. Balch CM, Gershenwald JE, Soong SJ, Thompson JF, Atkins MB, Byrd DR, Buzaid AC, Cochran AJ, Coit DG, Ding S, Eggermont AM, Flaherty KT, Gimotty PA, Kirkwood JM, McMasters KM, Mihm MC, Jr., et al. Final version of 2009 AJCC melanoma staging and classification. J Clin Oncol. 2009; 27:6199-6206.
38. Heidenreich B, Rachakonda PS, Hosen I, Volz F, Hemminki K, Weyerbrock A and Kumar R. TERT promoter mutations and telomere length in adult malignant gliomas and recurrences. Oncotarget. 2015;6:10617-33.
39. Smeds J, Berggren P, Ma X, Xu Z, Hemminki K and Kumar R. Genetic status of cell cycle regulators in squamous cell carcinoma of the oesophagus: the CDKN2A (p16(INK4a) and p14(ARF) ) and p53 genes are major targets for inactivation. Carcinogenesis. 2002; 23:645-655.
40. Rachakonda PS, Hosen I, de Verdier PJ, Fallah M, Heidenreich B, Ryk C, Wiklund NP, Steineck G, Schadendorf D, Hemminki K and Kumar R. TERT promoter mutations in bladder cancer affect patient survival and disease recurrence through modification by a common polymorphism. Proc Natl Acad Sci U S A. 2013; 110:17426-17431.
41. McKenna A, Hanna M, Banks E, Sivachenko A, Cibulskis K, Kernytsky A, Garimella K, Altshuler D, Gabriel S, Daly M and DePristo MA. The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. Genome Res. 2010; 20:1297-1303.
42. Li H and Durbin R. Fast and accurate long-read alignment with Burrows-Wheeler transform. Bioinformatics. 2010; 26:589-595.
43. Cibulskis K, Lawrence MS, Carter SL, Sivachenko A, Jaffe D, Sougnez C, Gabriel S, Meyerson M, Lander ES and Getz G. Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples. Nat Biotechnol. 2013; 31:213-219.
44. Robinson JT, Thorvaldsdottir H, Winckler W, Guttman M, Lander ES, Getz G and Mesirov JP. Integrative genomics viewer. Nature biotechnology. 2011; 29:24-26.
45. Wang K, Li M and Hakonarson H. ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data. Nucleic Acids Res. 2010; 38:e164.
46. Abecasis GR, Altshuler D, Auton A, Brooks LD, Durbin RM, Gibbs RA, Hurles ME and McVean GA. A map of human genome variation from population-scale sequencing. Nature. 2010; 467:1061-1073.
47. Wang J, Zhuang J, Iyer S, Lin XY, Greven MC, Kim BH, Moore J, Pierce BG, Dong X, Virgil D, Birney E, Hung JH and Weng Z. Factorbook.org: a Wiki-based database for transcription factor-binding data generated by the ENCODE consortium. Nucleic acids research. 2013; 41:D171-176.